Latest Strategic Investment News

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

BSP Financial Group has reported a robust 12.9% increase in net profit for 2025, underpinned by strong revenue growth and strategic restructuring, including converting its Fiji branch into a wholly owned subsidiary.

Latitude Group Holdings Limited reported a robust 59% increase in Cash NPAT for FY25, driven by strong volume growth and margin expansion, while declaring a fully franked 9.00 cents per share dividend.

Peter Warren Automotive Holdings reported a 3.2% revenue increase to $1.268 billion and more than doubled its profit after tax to $7.435 million in the first half of FY26, declaring a fully franked interim dividend of 3.0 cents per share.

MaxiPARTS Limited reported a modest 1.8% revenue increase to $139.3 million for the half-year ended December 2025, while net profit after tax dipped slightly by 2%. The company raised its interim dividend to 4.15 cents per share, reflecting confidence in its growth initiatives and cash flow outlook.

360 Capital REIT reported a 63.2% rise in statutory profit to $3.1 million for H1 2026, maintaining distributions and expanding its portfolio with a $10 million Sydney apartment block investment.

Universal Store Holdings has reported a robust first half of FY26, with sales and profits climbing significantly across its key brands, supported by margin gains and strategic investments.

PlaySide Studios has secured a global publishing agreement with Swedish developer MVRX Games for the upcoming co-op platformer 'Dew', aiming for a 2028 PC and console release. This deal marks a strategic expansion of PlaySide’s publishing portfolio, backed by a multi-million AUD investment.

Australian Vintage reports steady first-half sales and outlines a robust strategy focused on innovation, portfolio diversification, and global expansion to meet full-year growth targets.

Emeco Holdings Limited has reported a solid 15% increase in net profit for the half year ending December 2025, alongside a 9% rise in revenue, while opting to maintain a no-dividend payout policy.